Biomarkers from discovery to clinical practice
February 12, 2025 @ 13:00 – 14:00 CET
Welcome to Professor Leonidas Alexopoulos‘s seminar (National Technical University of Athens and Protavio Ltd.)
who will share his experience about diseasebiomarkers from discovery to clinical practice providing both an academic and industryperspective.
When: February 12th 2025 at 1 pm
Where: SciLifeLab, Lunch Room Gamma-7
Translating a multiplex biomarker discovery project to clinical practice is a comprehensive process necessitating strong research and business aptitude. As a professor in Systems Bioengineering at the National Technical University of Athens and as an entrepreneur and co-founder of Protavio, a multiplex biomarker company using Luminex and Olink technologies, I have seen both worlds of research and commercialization. Bridging the gap between the two worlds is of utmost importance to amplify the impact of academic research beyond traditional academic accolades such as paper citations and h-index. This talk will encapsulate insights from approximately 150 biomarker projects undertaken by Protavio in the last decade and discuss important aspects of improving the research-to-clinic biomarker translation. Several important aspects of this process will be discussed that span beyond assay development and clinical validation and include: commercialization plan, platform selection, software development, stakeholder analysis, IVDR / regulatory requirements, reimbursement strategy, intellectual property basics, and stringent GMP and ISO13485 production. By understanding the importance of these elements holistically, researchers will be in a better position to assess the commercialization potential and clinical usability of their multiplex biomarker projects.
claudia.fredolini@scilifelab.se
Google Calendar 